9209 is a clinical research site located in Buffalo, New York, United States 14263.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
9209 has participated in 1 clinical trials.
Therapeutic areas: Solid Tumor.
Sponsors: Black Diamond Therapeutics, Inc..
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
9209 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
9209 has 1 clinical trials on record. Their work covers Solid Tumor.
9209 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.